Company Search:
Advanced Search
Sponsored Links
Egypt International Pharmaceuticals Company Snapshot
Egypt International Pharmaceuticals operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Egypt International Pharmaceuticals with three other pharmaceutical manufacturers in Middle East: Dar Al Dawa Development & Investment of Jordan (2016 sales of 60.88 million Jordanian Dinars [US$85.86 million] of which 80% was Pharmaceuticals), Enzymotec Ltd of Israel (182.39 million Israel Shekels [US$51.77 million] of which 104% was Nutrition), and Glaxo Smith Kline (1.17 billion Egyptian Pounds [US$65.21 million] of which 93% was Medical Sector).

Sales Analysis. During the year ended December of 2016, sales at Egypt International Pharmaceuticals were 1.97 billion Egyptian Pounds (US$110.15 million). This is an increase of 16.0% versus 2015, when the company's sales were 1.70 billion Egyptian Pounds. This was the fifth consecutive year of sales increases at Egypt International Pharmaceuticals (and since 2011, sales have increased a total of 69%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Egypt International Pharmaceuticals
  Stock Performance Chart for Egypt International Pharmaceuticals
  Stock Data: Recent Stock Performance:
  Current Price (12/14/2017): 125.00
(Figures in Egyptian Pounds)
1 Week 0.0%   13 Weeks 0.0%  
4 Weeks 5.0%   52 Weeks 47.1%  
Egypt International Pharmaceuticals Key Data:
  Ticker: PHAR Country: Egypt
  Exchanges: CAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,969,103,027
(Year Ending Jan 2017).
Employees: 2,039
  Currency: Egyptian Pounds Market Cap: 9,917,050,000
  Fiscal Yr Ends: December Shares Outstanding: 79,336,400
  Share Type: Ordinary Closely Held Shares: 39,078,912
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.